Session Track · PDDS 2027 · Track 03

Pharmaceutical Microbiology and Biotechnology at PDDS 2027

Part of the PDDS 2027 scientific program · Olympia Hotel, Events & Spa, Valencia, Spain · September 13–15, 2027

About the Pharmaceutical Microbiology and Biotechnology Session

  • Controlled environments
  • Antimicrobial activity
  • Microbiology
  • Molecular biology
  • Biochemistry
  • Genetics

Pharmaceutical Microbiology is the branch of Microbiology, which involves the study of microorganisms associated with the manufacture of pharmaceuticals. e.g. controlling the number of microorganisms in a process environment, excluding microorganisms and microbial by-products like exotoxin and endotoxin from water and other starting materials, and ensures the sterile finished pharmaceutical product. Pharmaceutical microbiology includes the research and development of anti-infective agents, where the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and in the manufacture of pharmaceutical products likes insulin and human growth hormone.

Microbiology contains numerous sub-divisions which include:

  • Virology
  • Bacteriology
  • Protistology
  • Mycology
  • Immunology
  • Parasitology

Pharmaceutical Biotechnology is simply defined as, the science that covers all the technologies required for the production, manufacturing, and registration of biological drugs.

It Includes:

 

Featured Speakers — Pharmaceutical Microbiology and Biotechnology 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Pharmaceutical Microbiology and Biotechnology Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at PDDS 2027

Why Attend the Pharmaceutical Microbiology and Biotechnology Conference 2027

Present Your Research

Oral and poster slots for original Pharmaceutical Microbiology and Biotechnology work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Learn from Keynotes

Plenary lectures from leading voices shaping Pharmaceutical Microbiology and Biotechnology research and practice.

Hybrid Flexibility

Attend in person in Valencia or join virtually — same program, same certificate.

Join PDDS 2027 for the Pharmaceutical Microbiology and Biotechnology track

Oral and poster slots for your work — in person in Valencia or online. Not presenting? Attend as a delegate to learn from the field.

Pharmaceutical Microbiology and Biotechnology Conference 2027 — FAQs

What is the Pharmaceutical Microbiology and Biotechnology track at PDDS 2027?

The Pharmaceutical Microbiology and Biotechnology track is a dedicated stream within PDDS 2027 covering the latest research, clinical innovation, and best practice in Pharmaceutical Microbiology and Biotechnology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Pharmaceutical Microbiology and Biotechnology sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Pharmaceutical Microbiology and Biotechnology are all welcome — whether presenting or attending.

Can I present my research in the Pharmaceutical Microbiology and Biotechnology track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.

Is virtual attendance available for Pharmaceutical Microbiology and Biotechnology sessions?

Yes. PDDS 2027 is a hybrid conference — attend the Pharmaceutical Microbiology and Biotechnology track in person in Valencia or join live online, with on-demand access afterward.

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.